US2008058543A1PendingUtilityA1
Process for making chiral 1,4-disubstituted piperazines
Est. expiryMar 12, 2022(expired)· nominal 20-yr term from priority
C07D 319/18C07C 309/06C07C 229/12C07B 2200/07C07D 487/10A61P 25/00C07D 405/06C07D 405/10
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process for a stereoselective preparation of novel chiral nitrogen mustard derivatives useful in synthesizing optically active 1,4-disubstituted piperazines of formula: wherein R, Ar, and Q are defined as set forth herein, and intermediate compounds therefor. The 1,4-disubstituted piperazines act as 5HT1A receptor binding agents useful in the treatment of Central Nervous System (CNS) disorders.
Claims
exact text as granted — not AI-modified1 . A compound of formula II
wherein R and R′ each independently represents a lower alkyl of C 1 -C 3 , and optical isomers and salts thereof.
2 . A compound according to claim 1 wherein said salt is:
3 . A compound selected from the group consisting of
N,N-bis(2-chloroethyl)-(R)-alanine methyl ester, trifluoromethanesulfonate; and N,N-bis(2-chloroethyl)-(R)-alanine ethyl ester, trifluoromethanesulfonate; and the optical isomers thereof.Join the waitlist — get patent alerts
Track US2008058543A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.